Gregory W Albers1, Jean-Marc Olivot. Show Affiliations » 1. Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305, USA. albers@stanford.edu
Abstract
Entities: Disease
Mesh: See more » AgedCerebral Hemorrhage/chemically inducedDrug-Related Side Effects and Adverse ReactionsFibrinolytic Agents/administration & dosageFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHumansInjections, IntravenousMulticenter Studies as TopicPatient SelectionRandomized Controlled Trials as TopicStroke/drug therapyStroke/mortalityTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/adverse effectsTissue Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2007 PMID: 17258646 DOI: 10.1016/S0140-6736(07)60120-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321